Supernus Pharmaceuticals Stock Performance
as on October 24, 2026 at 6:25 am IST
Day's Low
Day's High
$39.96$41.95
1.26%
Downside
3.66%
Upside
52 Week's Low
52 Week's High
$37.54$59.687.24%
Downside
47.47%
Upside
Supernus Pharmaceuticals share price movements today
- Previous Close
- $42.07
- Open
- $41.95
- Volume
- 858.8K
- Market Cap
- $2.4B
- Day's Low - High
- $39.96 - $41.95
- 52 Week Low - High
- $37.54 - $59.68
Supernus Pharmaceuticals Historical Returns
- 1 Month Return
- -3.04 %
- 3 Month Return
- -10.85 %
- 1 Year Return
- -19.13 %
- 3 Year Return
- + 77.06 %
- 5 Year Return
- + 41.17 %
Supernus Pharmaceuticals Stock Fundamentals & Key Indicators
Check Supernus Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.4B
EPS (TTM)
-1.9214
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.11%
PE Ratio (TTM)
-21.45
Industry PE ratio
24.77
PEG Ratio
0.21
EBITDA
-15.9M
Revenue (TTM)
830.4M
Profit Margin
88.07%
Return On Equity TTM
-10.42%
Supernus Pharmaceuticals vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Supernus Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $2.4B | 41.17% | -21.45 | 88.07% | 0.00% | |
| Buy | $41.2B | NA | 63.90 | 47.54% | 1.08% | |
| StrongBuy | $24.2B | 206.16% | 18.64 | 86.14% | 0.00% | |
| Buy | $21.4B | 32.57% | -51.25 | 34.83% | 2.60% | |
| Buy | $44.3B | NA | 20.54 | 65.57% | 1.98% |
Stock Returns calculator for Supernus Pharmaceuticals Stock including INR - Dollar returns
The Supernus Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Supernus Pharmaceuticals investment value today
Current value as on today
₹84,144
Returns
Returns from Supernus Pharmaceuticals Stock
Dollar Impact
₹6,347 (+6.35%)
Analyst Recommendation on Supernus Pharmaceuticals Stock
Based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Supernus Pharmaceuticals. Average target price of $60.5
Supernus Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on Supernus Pharmaceuticals.
What analysts predicted
33.11%UPSIDE
Target Price
$60.5
Current Price
$40.47
Analyzed by
1 Analysts
High
$66
Target
$60.50
Low
$66
Supernus Pharmaceuticals target price $60.5, a slight upside of 33.11% compared to current price of $40.47. According to 1 analysts rating.
Indian Investors' Interest in Supernus Pharmaceuticals Stock
Search interest for Supernus Pharmaceuticals Stock has increased by 61% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:61% versus previous 30 day period
Supernus Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
Supernus Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
Supernus Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
Supernus Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
Supernus Pharmaceuticals News & Key Events
Insights on Supernus Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, SUPN stock has moved up by 11.1%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 207.70M → 219.05M (in $), with an average increase of 5.2% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Viatris Inc. Common Stock has given 79.2% return, outperforming this stock by 98.3%
- NO EFFECT
Against Peers
In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 107.2% return, outperforming this stock by 30.1%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -2.29M → -58.37M (in $), with an average decrease of 2445.6% per quarter
About Supernus Pharmaceuticals
| Organisation | Supernus Pharmaceuticals |
| Headquarters | 9715 Key West Avenue, Rockville, MD, 20850, US |
| Industry | Drug Manufacturers - Specialty & Generic |
| CEO | Jack A. Khattar |
Key Management of Supernus Pharmaceuticals
Name | Title |
|---|---|
Mr. Jack A. Khattar M.B.A. | Founder, President, CEO, Secretary & Director |
Mr. Timothy C. Dec | Senior VP & CFO |
Dr. Padmanabh P. Bhatt Ph.D. | Chief Scientific Officer & Senior VP of Intellectual Property |
Mr. Kevin T. Anderson Esq. | Compliance Officer |
Dr. Bryan A. Roecklein Ph.D. | Senior VP & Chief Business Officer |
Mr. Frank Mottola | Senior VP & Chief Technology Operations Officer |
Dr. Jonathan Rubin M.B.A., M.D. | Senior VP of Research & Development and Chief Medical Officer |
Mr. Taylor Raiford | Senior Vice President of Sales |
Dr. William Todd Horich M.B.A., Ph.D. | Senior VP & Chief Commercial Officer |
Mr. Jeff Bozick | Senior Vice President of Supply Chain |
FAQs
What is Supernus Pharmaceuticals share price today?
Supernus Pharmaceuticals share price today is $40.47 as on . Supernus Pharmaceuticals share today touched a day high of $41.95 and a low of $39.96.
What is the 52 week high and 52 week low for Supernus Pharmaceuticals share?
Supernus Pharmaceuticals share touched a 52 week high of $59.68 on and a 52 week low of $37.54 on . Supernus Pharmaceuticals stock price today i.e. is trending at $40.47,which is 32.19% down from its 52 week high and 7.81% up from its 52 week low.
What is Supernus Pharmaceuticals's market capitalisation today?
Supernus Pharmaceuticals market capitalisation is $0.00T as on .
How to invest in Supernus Pharmaceuticals Stock (SUPN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Supernus Pharmaceuticals on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Supernus Pharmaceuticals Stock (SUPN) from India?
Indian investors can start investing in Supernus Pharmaceuticals (SUPN) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Supernus Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Supernus Pharmaceuticals share’s latest price of $40.47 as on October 24, 2026 at 12:55 am IST, you will get 0.2471 shares of Supernus Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Supernus Pharmaceuticals has given to Indian investors in the last 5 years?
Supernus Pharmaceuticals stock has given 41.17% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?